0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biologic Imaging Contrast Agent Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-35I8246
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biologic Imaging Contrast Agent Market Insights Forecast to 2028
BUY CHAPTERS

Global Biologic Imaging Contrast Agent Market Research Report 2025

Code: QYRE-Auto-35I8246
Report
July 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biologic Imaging Contrast Agent Market Size

The global market for Biologic Imaging Contrast Agent was valued at US$ 10480 million in the year 2024 and is projected to reach a revised size of US$ 24980 million by 2031, growing at a CAGR of 13.4% during the forecast period.

Biologic Imaging Contrast Agent Market

Biologic Imaging Contrast Agent Market

Bioimaging contrast agents are a type of special drugs or compounds used in medical imaging technology. By introducing specific molecules or substances into the body, they can enhance medical images and help doctors diagnose and treat diseases. One of the future trends is the development of multimodal imaging contrast agents that can be used simultaneously in different imaging techniques to provide more comprehensive information. For example, using MRI and PET (positron emission tomography) imaging contrast agents together can provide more precise diagnostic results.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologic Imaging Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Imaging Contrast Agent.
The Biologic Imaging Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologic Imaging Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic Imaging Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biologic Imaging Contrast Agent Market Report

Report Metric Details
Report Name Biologic Imaging Contrast Agent Market
Accounted market size in year US$ 10480 million
Forecasted market size in 2031 US$ 24980 million
CAGR 13.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bracco, Bayer HealthCare, Hengrui Medicine, GE Healthcare, YRPG, BeiLu Pharma, Guerbet, Starry Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biologic Imaging Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biologic Imaging Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Biologic Imaging Contrast Agent Market growing?

Ans: The Biologic Imaging Contrast Agent Market witnessing a CAGR of 13.4% during the forecast period 2025-2031.

What is the Biologic Imaging Contrast Agent Market size in 2031?

Ans: The Biologic Imaging Contrast Agent Market size in 2031 will be US$ 24980 million.

Who are the main players in the Biologic Imaging Contrast Agent Market report?

Ans: The main players in the Biologic Imaging Contrast Agent Market are Bracco, Bayer HealthCare, Hengrui Medicine, GE Healthcare, YRPG, BeiLu Pharma, Guerbet, Starry Pharmaceutical

What are the Application segmentation covered in the Biologic Imaging Contrast Agent Market report?

Ans: The Applications covered in the Biologic Imaging Contrast Agent Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Biologic Imaging Contrast Agent Market report?

Ans: The Types covered in the Biologic Imaging Contrast Agent Market report are CT Contrast Reagents, Magnetic Resonance Imaging (MRI) Contrast Reagents, Ultrasound Contrast Reagents

Recommended Reports

Molecular Imaging Markets

Radiation & Therapy

Diagnostics & Detection

1 Biologic Imaging Contrast Agent Market Overview
1.1 Product Definition
1.2 Biologic Imaging Contrast Agent by Type
1.2.1 Global Biologic Imaging Contrast Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 CT Contrast Reagents
1.2.3 Magnetic Resonance Imaging (MRI) Contrast Reagents
1.2.4 Ultrasound Contrast Reagents
1.3 Biologic Imaging Contrast Agent by Application
1.3.1 Global Biologic Imaging Contrast Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Biologic Imaging Contrast Agent Market Size Estimates and Forecasts
1.4.1 Global Biologic Imaging Contrast Agent Revenue 2020-2031
1.4.2 Global Biologic Imaging Contrast Agent Sales 2020-2031
1.4.3 Global Biologic Imaging Contrast Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biologic Imaging Contrast Agent Market Competition by Manufacturers
2.1 Global Biologic Imaging Contrast Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biologic Imaging Contrast Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biologic Imaging Contrast Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biologic Imaging Contrast Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biologic Imaging Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biologic Imaging Contrast Agent, Product Type & Application
2.7 Global Key Manufacturers of Biologic Imaging Contrast Agent, Date of Enter into This Industry
2.8 Global Biologic Imaging Contrast Agent Market Competitive Situation and Trends
2.8.1 Global Biologic Imaging Contrast Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biologic Imaging Contrast Agent Players Market Share by Revenue
2.8.3 Global Biologic Imaging Contrast Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biologic Imaging Contrast Agent Market Scenario by Region
3.1 Global Biologic Imaging Contrast Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biologic Imaging Contrast Agent Sales by Region: 2020-2031
3.2.1 Global Biologic Imaging Contrast Agent Sales by Region: 2020-2025
3.2.2 Global Biologic Imaging Contrast Agent Sales by Region: 2026-2031
3.3 Global Biologic Imaging Contrast Agent Revenue by Region: 2020-2031
3.3.1 Global Biologic Imaging Contrast Agent Revenue by Region: 2020-2025
3.3.2 Global Biologic Imaging Contrast Agent Revenue by Region: 2026-2031
3.4 North America Biologic Imaging Contrast Agent Market Facts & Figures by Country
3.4.1 North America Biologic Imaging Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biologic Imaging Contrast Agent Sales by Country (2020-2031)
3.4.3 North America Biologic Imaging Contrast Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biologic Imaging Contrast Agent Market Facts & Figures by Country
3.5.1 Europe Biologic Imaging Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biologic Imaging Contrast Agent Sales by Country (2020-2031)
3.5.3 Europe Biologic Imaging Contrast Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biologic Imaging Contrast Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Biologic Imaging Contrast Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biologic Imaging Contrast Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Biologic Imaging Contrast Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Biologic Imaging Contrast Agent Market Facts & Figures by Country
3.7.1 Latin America Biologic Imaging Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biologic Imaging Contrast Agent Sales by Country (2020-2031)
3.7.3 Latin America Biologic Imaging Contrast Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biologic Imaging Contrast Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Biologic Imaging Contrast Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biologic Imaging Contrast Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biologic Imaging Contrast Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biologic Imaging Contrast Agent Sales by Type (2020-2031)
4.1.1 Global Biologic Imaging Contrast Agent Sales by Type (2020-2025)
4.1.2 Global Biologic Imaging Contrast Agent Sales by Type (2026-2031)
4.1.3 Global Biologic Imaging Contrast Agent Sales Market Share by Type (2020-2031)
4.2 Global Biologic Imaging Contrast Agent Revenue by Type (2020-2031)
4.2.1 Global Biologic Imaging Contrast Agent Revenue by Type (2020-2025)
4.2.2 Global Biologic Imaging Contrast Agent Revenue by Type (2026-2031)
4.2.3 Global Biologic Imaging Contrast Agent Revenue Market Share by Type (2020-2031)
4.3 Global Biologic Imaging Contrast Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biologic Imaging Contrast Agent Sales by Application (2020-2031)
5.1.1 Global Biologic Imaging Contrast Agent Sales by Application (2020-2025)
5.1.2 Global Biologic Imaging Contrast Agent Sales by Application (2026-2031)
5.1.3 Global Biologic Imaging Contrast Agent Sales Market Share by Application (2020-2031)
5.2 Global Biologic Imaging Contrast Agent Revenue by Application (2020-2031)
5.2.1 Global Biologic Imaging Contrast Agent Revenue by Application (2020-2025)
5.2.2 Global Biologic Imaging Contrast Agent Revenue by Application (2026-2031)
5.2.3 Global Biologic Imaging Contrast Agent Revenue Market Share by Application (2020-2031)
5.3 Global Biologic Imaging Contrast Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bracco
6.1.1 Bracco Company Information
6.1.2 Bracco Description and Business Overview
6.1.3 Bracco Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bracco Biologic Imaging Contrast Agent Product Portfolio
6.1.5 Bracco Recent Developments/Updates
6.2 Bayer HealthCare
6.2.1 Bayer HealthCare Company Information
6.2.2 Bayer HealthCare Description and Business Overview
6.2.3 Bayer HealthCare Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer HealthCare Biologic Imaging Contrast Agent Product Portfolio
6.2.5 Bayer HealthCare Recent Developments/Updates
6.3 Hengrui Medicine
6.3.1 Hengrui Medicine Company Information
6.3.2 Hengrui Medicine Description and Business Overview
6.3.3 Hengrui Medicine Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hengrui Medicine Biologic Imaging Contrast Agent Product Portfolio
6.3.5 Hengrui Medicine Recent Developments/Updates
6.4 GE Healthcare
6.4.1 GE Healthcare Company Information
6.4.2 GE Healthcare Description and Business Overview
6.4.3 GE Healthcare Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GE Healthcare Biologic Imaging Contrast Agent Product Portfolio
6.4.5 GE Healthcare Recent Developments/Updates
6.5 YRPG
6.5.1 YRPG Company Information
6.5.2 YRPG Description and Business Overview
6.5.3 YRPG Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 YRPG Biologic Imaging Contrast Agent Product Portfolio
6.5.5 YRPG Recent Developments/Updates
6.6 BeiLu Pharma
6.6.1 BeiLu Pharma Company Information
6.6.2 BeiLu Pharma Description and Business Overview
6.6.3 BeiLu Pharma Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BeiLu Pharma Biologic Imaging Contrast Agent Product Portfolio
6.6.5 BeiLu Pharma Recent Developments/Updates
6.7 Guerbet
6.7.1 Guerbet Company Information
6.7.2 Guerbet Description and Business Overview
6.7.3 Guerbet Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Guerbet Biologic Imaging Contrast Agent Product Portfolio
6.7.5 Guerbet Recent Developments/Updates
6.8 Starry Pharmaceutical
6.8.1 Starry Pharmaceutical Company Information
6.8.2 Starry Pharmaceutical Description and Business Overview
6.8.3 Starry Pharmaceutical Biologic Imaging Contrast Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Starry Pharmaceutical Biologic Imaging Contrast Agent Product Portfolio
6.8.5 Starry Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biologic Imaging Contrast Agent Industry Chain Analysis
7.2 Biologic Imaging Contrast Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biologic Imaging Contrast Agent Production Mode & Process Analysis
7.4 Biologic Imaging Contrast Agent Sales and Marketing
7.4.1 Biologic Imaging Contrast Agent Sales Channels
7.4.2 Biologic Imaging Contrast Agent Distributors
7.5 Biologic Imaging Contrast Agent Customer Analysis
8 Biologic Imaging Contrast Agent Market Dynamics
8.1 Biologic Imaging Contrast Agent Industry Trends
8.2 Biologic Imaging Contrast Agent Market Drivers
8.3 Biologic Imaging Contrast Agent Market Challenges
8.4 Biologic Imaging Contrast Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Biologic Imaging Contrast Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biologic Imaging Contrast Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biologic Imaging Contrast Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biologic Imaging Contrast Agent Sales (Kiloton) of Key Manufacturers (2020-2025)
 Table 5. Global Biologic Imaging Contrast Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biologic Imaging Contrast Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biologic Imaging Contrast Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biologic Imaging Contrast Agent Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biologic Imaging Contrast Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biologic Imaging Contrast Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biologic Imaging Contrast Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Biologic Imaging Contrast Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biologic Imaging Contrast Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Imaging Contrast Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biologic Imaging Contrast Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biologic Imaging Contrast Agent Sales by Region (2020-2025) & (Kiloton)
 Table 18. Global Biologic Imaging Contrast Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Biologic Imaging Contrast Agent Sales by Region (2026-2031) & (Kiloton)
 Table 20. Global Biologic Imaging Contrast Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Biologic Imaging Contrast Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biologic Imaging Contrast Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Biologic Imaging Contrast Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biologic Imaging Contrast Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Biologic Imaging Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biologic Imaging Contrast Agent Sales by Country (2020-2025) & (Kiloton)
 Table 27. North America Biologic Imaging Contrast Agent Sales by Country (2026-2031) & (Kiloton)
 Table 28. North America Biologic Imaging Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biologic Imaging Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biologic Imaging Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biologic Imaging Contrast Agent Sales by Country (2020-2025) & (Kiloton)
 Table 32. Europe Biologic Imaging Contrast Agent Sales by Country (2026-2031) & (Kiloton)
 Table 33. Europe Biologic Imaging Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biologic Imaging Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biologic Imaging Contrast Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biologic Imaging Contrast Agent Sales by Region (2020-2025) & (Kiloton)
 Table 37. Asia Pacific Biologic Imaging Contrast Agent Sales by Region (2026-2031) & (Kiloton)
 Table 38. Asia Pacific Biologic Imaging Contrast Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biologic Imaging Contrast Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biologic Imaging Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biologic Imaging Contrast Agent Sales by Country (2020-2025) & (Kiloton)
 Table 42. Latin America Biologic Imaging Contrast Agent Sales by Country (2026-2031) & (Kiloton)
 Table 43. Latin America Biologic Imaging Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biologic Imaging Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biologic Imaging Contrast Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biologic Imaging Contrast Agent Sales by Country (2020-2025) & (Kiloton)
 Table 47. Middle East and Africa Biologic Imaging Contrast Agent Sales by Country (2026-2031) & (Kiloton)
 Table 48. Middle East and Africa Biologic Imaging Contrast Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biologic Imaging Contrast Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biologic Imaging Contrast Agent Sales (Kiloton) by Type (2020-2025)
 Table 51. Global Biologic Imaging Contrast Agent Sales (Kiloton) by Type (2026-2031)
 Table 52. Global Biologic Imaging Contrast Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Biologic Imaging Contrast Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Biologic Imaging Contrast Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biologic Imaging Contrast Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biologic Imaging Contrast Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Biologic Imaging Contrast Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Biologic Imaging Contrast Agent Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Biologic Imaging Contrast Agent Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Biologic Imaging Contrast Agent Sales (Kiloton) by Application (2020-2025)
 Table 61. Global Biologic Imaging Contrast Agent Sales (Kiloton) by Application (2026-2031)
 Table 62. Global Biologic Imaging Contrast Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Biologic Imaging Contrast Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Biologic Imaging Contrast Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biologic Imaging Contrast Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biologic Imaging Contrast Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Biologic Imaging Contrast Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Biologic Imaging Contrast Agent Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Biologic Imaging Contrast Agent Price (US$/Ton) by Application (2026-2031)
 Table 70. Bracco Company Information
 Table 71. Bracco Description and Business Overview
 Table 72. Bracco Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Bracco Biologic Imaging Contrast Agent Product
 Table 74. Bracco Recent Developments/Updates
 Table 75. Bayer HealthCare Company Information
 Table 76. Bayer HealthCare Description and Business Overview
 Table 77. Bayer HealthCare Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Bayer HealthCare Biologic Imaging Contrast Agent Product
 Table 79. Bayer HealthCare Recent Developments/Updates
 Table 80. Hengrui Medicine Company Information
 Table 81. Hengrui Medicine Description and Business Overview
 Table 82. Hengrui Medicine Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Hengrui Medicine Biologic Imaging Contrast Agent Product
 Table 84. Hengrui Medicine Recent Developments/Updates
 Table 85. GE Healthcare Company Information
 Table 86. GE Healthcare Description and Business Overview
 Table 87. GE Healthcare Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. GE Healthcare Biologic Imaging Contrast Agent Product
 Table 89. GE Healthcare Recent Developments/Updates
 Table 90. YRPG Company Information
 Table 91. YRPG Description and Business Overview
 Table 92. YRPG Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. YRPG Biologic Imaging Contrast Agent Product
 Table 94. YRPG Recent Developments/Updates
 Table 95. BeiLu Pharma Company Information
 Table 96. BeiLu Pharma Description and Business Overview
 Table 97. BeiLu Pharma Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. BeiLu Pharma Biologic Imaging Contrast Agent Product
 Table 99. BeiLu Pharma Recent Developments/Updates
 Table 100. Guerbet Company Information
 Table 101. Guerbet Description and Business Overview
 Table 102. Guerbet Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Guerbet Biologic Imaging Contrast Agent Product
 Table 104. Guerbet Recent Developments/Updates
 Table 105. Starry Pharmaceutical Company Information
 Table 106. Starry Pharmaceutical Description and Business Overview
 Table 107. Starry Pharmaceutical Biologic Imaging Contrast Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Starry Pharmaceutical Biologic Imaging Contrast Agent Product
 Table 109. Starry Pharmaceutical Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Biologic Imaging Contrast Agent Distributors List
 Table 113. Biologic Imaging Contrast Agent Customers List
 Table 114. Biologic Imaging Contrast Agent Market Trends
 Table 115. Biologic Imaging Contrast Agent Market Drivers
 Table 116. Biologic Imaging Contrast Agent Market Challenges
 Table 117. Biologic Imaging Contrast Agent Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biologic Imaging Contrast Agent
 Figure 2. Global Biologic Imaging Contrast Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biologic Imaging Contrast Agent Market Share by Type: 2024 & 2031
 Figure 4. CT Contrast Reagents Product Picture
 Figure 5. Magnetic Resonance Imaging (MRI) Contrast Reagents Product Picture
 Figure 6. Ultrasound Contrast Reagents Product Picture
 Figure 7. Global Biologic Imaging Contrast Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Biologic Imaging Contrast Agent Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Other
 Figure 12. Global Biologic Imaging Contrast Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Biologic Imaging Contrast Agent Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Biologic Imaging Contrast Agent Sales (2020-2031) & (Kiloton)
 Figure 15. Global Biologic Imaging Contrast Agent Average Price (US$/Ton) & (2020-2031)
 Figure 16. Biologic Imaging Contrast Agent Report Years Considered
 Figure 17. Biologic Imaging Contrast Agent Sales Share by Manufacturers in 2024
 Figure 18. Global Biologic Imaging Contrast Agent Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Biologic Imaging Contrast Agent Players: Market Share by Revenue in Biologic Imaging Contrast Agent in 2024
 Figure 20. Biologic Imaging Contrast Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Biologic Imaging Contrast Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Biologic Imaging Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 23. North America Biologic Imaging Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 24. United States Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Biologic Imaging Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 27. Europe Biologic Imaging Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Biologic Imaging Contrast Agent Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Biologic Imaging Contrast Agent Revenue Market Share by Region (2020-2031)
 Figure 35. China Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Biologic Imaging Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Biologic Imaging Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Biologic Imaging Contrast Agent Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Biologic Imaging Contrast Agent Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Biologic Imaging Contrast Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Biologic Imaging Contrast Agent by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Biologic Imaging Contrast Agent by Type (2020-2031)
 Figure 57. Global Biologic Imaging Contrast Agent Price (US$/Ton) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Biologic Imaging Contrast Agent by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Biologic Imaging Contrast Agent by Application (2020-2031)
 Figure 60. Global Biologic Imaging Contrast Agent Price (US$/Ton) by Application (2020-2031)
 Figure 61. Biologic Imaging Contrast Agent Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD